Head of Business Management
As Head of Business Management Danielle has strategic oversight and responsibility for the business management of the Genomic Surveillance Unit (GSU).
She is responsible for providing support to the Director of the Genomic Surveillance Unit (GSU) in strategic planning and implementations. Alongside providing assurance to the Chief Operating Officer (COO) of the GSU that the Unit operates on a financially viable basis, ensures compliance with all internal policies, processes and procedures and navigates the operational requirements of working with partners and managing exceptions to minimise risk.
With an awareness of the bigger picture across Sanger and in the context of genomics and global health, she develops and implement proportional and pragmatic systems that facilitate the international-scale projects and partnerships necessary to become the world leader in delivering longitudinal genomic data on important pathogen and vector species
Appointed Head of Business Management to the Genomic Surveillance Unit (GSU)
Appointed Business Manager to the Genomic Surveillance Unit (GSU)
Infection Genomics and Malaria programmes merged to become the Parasites and Microbes programme - Research Manager in Parasites and Microbes Programme
Appointed Research Manager in Infection Genomics
Appointed Research Administrator in Human Genetics
Appointed Illumina Agilent Pipeline Project Co-ordinator
Started at the WTSI as a Pathogen Finisher
Graduated University of Melbourne (Bachelor of Science - Hons)